Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Rad Laboratories

247.31
-9.3400-3.64%
Post-market: 247.30-0.0100+0.00%17:32 EDT
Volume:361.12K
Turnover:89.91M
Market Cap:6.93B
PE:-3.78
High:258.89
Open:257.14
Low:246.33
Close:256.65
Loading ...

BIO-key International Third Quarter 2024 Earnings: US$0.39 loss per share (vs US$1.26 loss in 3Q 2023)

Simply Wall St.
·
17 Nov 2024

BIO-key International Inc (BKYI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

GuruFocus.com
·
16 Nov 2024

KALA BIO Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Nov 2024

Bio-Rad Laboratories Down Over 6%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk

Dow Jones
·
16 Nov 2024

BIO-key Intl Q3 2024 Adj EPS $(0.39) Beats $(0.58) Estimate

Benzinga
·
15 Nov 2024

What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity?

Insider Monkey
·
13 Nov 2024

KALA BIO Inc reports results for the quarter - Earnings Summary

Reuters
·
12 Nov 2024

KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
12 Nov 2024

GSK to quit lobbying group BIO, STAT reports

TIPRANKS
·
11 Nov 2024

Binance Labs Enters DeSci Space with BIO Protocol Investment

BE[IN]CRYPTO
·
09 Nov 2024

KALA BIO Inc expected to post a loss of $2.43 a share - Earnings Preview

Reuters
·
09 Nov 2024

SAB BIO Q3 2024 Cash, Cash Equivalents Available $30.4M-$56.6M

Benzinga
·
07 Nov 2024

Interpreting Bio-Rad (BIO) International Revenue Trends

Zacks
·
04 Nov 2024

Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.
·
02 Nov 2024

Tiziana Life Sciences Highlights Advancements at BIO-Europe 2024

TIPRANKS
·
02 Nov 2024

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data

GlobeNewswire
·
02 Nov 2024